Background: Healthcare 5.0 represents a shift toward intelligent, human-centric care systems. Intensive care units generate vast amounts of data that require real-time decisions, but current decision support systems lack comprehensive frameworks for safe integration of artificial intelligence. Objective: We developed and validated the Learn–Predict–Monitor–Detect–Correct (LPMDC) framework as a methodology for systematic artificial intelligence integration across the critical care workflow. The framework improves predictive analytics, continuous patient monitoring, intelligent alerting, and therapeutic decision support while maintaining essential human clinical oversight. Methods: Framework development employed systematic theoretical modeling integrating Healthcare 5.0 principles, comprehensive literature synthesis covering 2020–2024, clinical workflow analysis across 15 international ICU sites, technology assessment of mature and emerging AI applications, and multi-round expert validation by 24 intensive care physicians and medical informaticists. Each LPMDC phase was designed with specific integration requirements, performance metrics, and safety protocols. Results: LPMDC implementation and aggregated evidence from prior studies demonstrated significant clinical improvements: 30% mortality reduction, 18% ICU length-of-stay decrease (7.5 to 6.1 days), 45% clinician cognitive load reduction, and 85% sepsis bundle compliance improvement. Machine learning algorithms achieved an 80% sensitivity for sepsis prediction three hours before clinical onset, with false-positive rates below 15%. Additional applications demonstrated effectiveness in predicting respiratory failure, preventing cardiovascular crises, and automating ventilator management. Digital twins technology enabled personalized treatment simulations, while the integration of the Internet of Medical Things provided comprehensive patient and environmental surveillance. Implementation challenges were systematically addressed through phased deployment strategies, staff training programs, and regulatory compliance frameworks. Conclusions: The Healthcare 5.0-enabled LPMDC framework provides the first comprehensive theoretical foundation for systematic AI integration in critical care while preserving human oversight and clinical safety. The cyclical five-phase architecture enables processing beyond traditional cognitive limits through continuous feedback loops and system optimization. Clinical validation demonstrates measurable improvements in patient outcomes, operational efficiency, and clinician satisfaction. Future developments incorporating quantum computing, federated learning, and explainable AI technologies offer additional advancement opportunities for next-generation critical care systems.

Ovarian cancer is the deadliest gynecologic cancer, mainly because it is often diagnosed late and resists standard treatments. The tumor microenvironment (TME) plays a major role in disease progression and therapy failure. Two key components of the TME, cancer-associated fibroblasts (CAFs) and tumor-associated macrophages (TAMs), create conditions that facilitate tumor growth and immune evasion. CAFs are highly diverse and originate from sources like fibroblasts and stem cells. They support cancer by remodeling the extracellular matrix, promoting angiogenesis, and releasing cytokines and growth factors that aid tumor survival. TAMs, which are usually in an M2 state, also promote metastasis and suppress immune responses by secreting immunosuppressive molecules. Together, CAFs and TAMs interact with cancer cells to activate pathways such as the TGF-β, IL-6, and PI3K/AKT pathways, which drive resistance to therapy. New treatments aim to block these interactions by targeting CAFs and TAMs through depletion, reprogramming, or pathway inhibition, often combined with immunotherapy. Advances such as single-cell sequencing and spatial transcriptomics now enable more precise identification of CAF and TAM subtypes, enabling more targeted therapies. This review summarizes their roles in epithelial ovarian cancer and explores how targeting these cells could improve outcomes.

Background: Nuclear medicine healthcare professionals (NMHP) sustain chronic occupational exposure to iodine-131 (I-131), conferring an elevated risk of radiation-induced solid thyroid cancer. Established radiobiological prediction tools derive risk coefficients from atomic bomb survivor data but are not configured for rapid individualized risk assessment in occupational exposure settings. This study examined whether machine learning algorithms can serve as high-precision computational surrogates for excess relative risk estimation in NMHP. Aim: The study aimed to (i) develop and validate three machine learning algorithms for predicting the excess relative risk per unit absorbed dose for radiation-induced solid thyroid cancer (ERR/Gy.RST), (ii) characterize relationships between dosimetric and demographic features and predicted risk, and (iii) identify the optimal algorithm for deployment in occupational health surveillance. Methods: A dataset of 4657 observations was constructed from Life Span Study-derived ERR/Gy parameters, adapted to occupational low-dose conditions, using a dose-and-dose-rate effectiveness factor of 2.0, per ICRP Publication 103. Five features (gender, age at exposure, current age, distance from the I-131 source, and cumulative absorbed dose in the thyroid) were used to train a decision tree regressor (dtcr), a random forest regressor (rfr), and a multilayer perceptron (MLP) neural network algorithm. Results: Cumulative absorbed dose in the thyroid correlated positively with ERR/Gy.RST (r = 0.63, p < 0.01), while radiation source distance demonstrated a strong inverse association (r = −0.38, p < 0.01). The MLP algorithm achieved R² score = 0.999, MSE = 0.002, and MAE = 0.010, substantially outperforming the rfr (R² score = 0.700, MSE = 0.410, MAE = 0.295) and the dtcr (R² score = 0.510, MSE = 0.654, MAE = 0.289). Conclusions: The MLP algorithm provides a high-fidelity surrogate for established ERR/Gy.RST projection tools in the NMHP context, enabling computationally efficient, feature-integrated occupational radiation-induced thyroid cancer risk quantification. These findings suggest that machine learning-based surrogate modeling is a practical, scalable complement for occupational health practitioners and radiation protection officers to support individualized surveillance of radiation-induced thyroid cancer risk in nuclear medicine departments.